Case Control Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Jan 16, 2023; 11(2): 342-356
Published online Jan 16, 2023. doi: 10.12998/wjcc.v11.i2.342
Table 1 Primers were used in this study for quantitative reverse transcription polymerase chain reaction
Gene
Forward primer
Reverse primer
IL-8CTCTTGGCAGCCTTCCTGATTTATGCACTGACATCTAAGTTCTTTAGCA
OAS2ACGTGACATCCTCGATAAAACTGGAACCCATCAAGGGACTTCTG
RSAD2TGAGGTTCTGCAAAGTAGAGTTGCGAGAATGTCCAAATACTCAC
CXCL10GTGGCATTCAAGGAGTACCTCTGATGGCCTTCGATTCTGGATT
Table 2 Patient Characteristics and plasma cytokine concentrations

Control (n = 20)
Sepsis (n = 19)
Psepsis vs control
Characteristics
Agea62.5 ± 9.858.13 ± 9.690.346
Male sexc1170.256
Hypertensionc460.480
DMc120.605
WBC, 109/Lb6.18 ± 1.5714.19 ± 8.02< 0.001
Site of infection
PneumoniaNA6
UrinaryNA6
AbdominalNA5
BacteraemiaNA2
UnknownNA3
Microbial data
Gram positiveNA3
Gram negativeNA13
FungiNA1
MixedNA2
UnknownNA4
Inflammation markers
TNF-α (pg/mL)b6.90 (4.94-9.45)26.10 (17.56-35.02)< 0.001
IL-6 (pg/mL)b7.33 (4.68-10.33)61.25 (37.54-87.30)< 0.001
IL-8 (pg/mL)b7.30 (5.11–9.00)19.59 (14.04-62.19)< 0.001
CRP (ng/mL)b158.62 (67.75-246.42)445.07 (382.31-549.73)< 0.001
sVCAM-1 (ng/mL)b89.22 (72.09-99.67)164.68 (134.15-198.55)< 0.001